News on countries and Ozempic (semaglutide) injection for Type 2 Diabetes

42 days ago

Screen the latest news on countries and Ozempic (semaglutide) injection for Type 2 Diabetes, extract the entire dataset or get visualizations.

Scope
Keywords:
Update

Related dashboards:

Latest news

The copycat brands that are replacing Ozempic in Russia

Read on: Financial Times link
42d ago

Obesity drugs Ozempic and Wegovy included in US price-cut talks

Read on: Financial Times link
82d ago

Ozempic competitor Mounjaro to soon hit Dutch market

Read on: NL Times link
184d ago

An Ozempic rival, exploding airplane tires, Elon Musk vs. Brazil: Business news roundup

Read on: Quartz link
220d ago

Mars's purchase of Kellanova suggests Ozempic hasn't curbed America's snacking just yet

Read on: Fast Company link
238d ago

Ozempic maker says unapproved compounded drugs being sold in Canada

Read on: Global News link
246d ago

Ozempic's biggest side effect: Turning Denmark into a 'pharmastate'?

Read on: NPR link
249d ago

Ozempic drugmaker is 'ripping off the American people' with high prices, says Bernie Sanders

Read on: NBC News link
294d ago

Ozempic and Wegovy could soon be challenged by China's generic competitors

Read on: Fast Company link
308d ago

Ozempic maker bringing weight-loss drug Wegovy to Canada starting next week

Read on: The Star link
342d ago

Ozempic among 'bogus' drug patents being challenged by U.S. to spur competition

Read on: Global News link
344d ago

Ozempic copycat arrives to Spain: What is the new weight loss drug and who can use it?

Read on: The Olive Press link
347d ago

Ozempic and Wegovy will keep boosting Denmark's GDP, report says

Read on: Quartz link
400d ago

Inside Novo Nordisk, the Danish Drugmaker Behind Ozempic

490d ago

This $2 billion unicorn startup is corporate America's secret weapon against Ozempic

Read on: Fast Company link
494d ago

Ozempic and Wegovy, Novo Nordisk’s Weight Loss Drugs, Reshape Denmark’s Economy

590d ago

Extract data

Extract all the news on this scope:

Visualize data

Trend on this scope:

Evolution through time

Source analysis:

Distribution of sources in the news

Section analysis:

Distribution of sections in the news

Current sentiment polarity: neutral (-0.05)

neutral 81%
negative 12%
positive 6%

Sentiment polarity through time